5FRI
ALK5 in complex witha an N-(4-anilino-2-pyridyl)acetamide inhibitor.
Summary for 5FRI
Entry DOI | 10.2210/pdb5fri/pdb |
Related | 5FQP 5FQR 5FQS 5FQT 5FQV |
Descriptor | TGF-BETA RECEPTOR TYPE-1, 1,2-ETHANEDIOL, N-[4-[(6-chloro-[1,3]dioxolo[4,5-b]pyridin-7-yl)amino]-2-pyridyl]cyclopropanecarboxamide, ... (4 entities in total) |
Functional Keywords | transferase |
Biological source | HOMO SAPIENS (HUMAN) |
Total number of polymer chains | 1 |
Total formula weight | 34836.38 |
Authors | Goldberg, F.W.,Daunt, P.,Pearson, S.E.,Greenwood, R.,Debreczeni, J.,Grist, M. (deposition date: 2015-12-17, release date: 2016-07-27, Last modification date: 2024-05-08) |
Primary citation | Goldberg, F.W.,Daunt, P.,Pearson, S.E.,Greenwood, R.,Debreczeni, J.,Grist, M. Identification and optimisation of a series of N-(4-anilino-2-pyridyl)acetamide activin receptor-like kinase 1 (ALK1) inhibitors Med. Chem. Commun., 7:1204-1208, 2016 Cited by DOI: 10.1039/C6MD00039HPDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2 Å) |
Structure validation
Download full validation report